ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

UT Health Science Center dedicates new Children’s Cancer Research Institute.

March 12, 2004

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993

Panel Suggests Test Of Paid Advertising For ACS: Roundup

August 7, 1992